CNS Pharmaceuticals, Inc. (CNSP): Total Assets
$8.62M
As of 2025-12-31
$21.94M
As of 2026-06-30
-12.9%
3-year compound annual growth
-11.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.62M | -0.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $8.70M | +411.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $1.70M | -87.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $13.05M | +49.1% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $8.76M | -44.8% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $15.85M | +100.4% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $7.91M | n/m | 2021-02-12, Balance as of period end |
| 2018-12-31 | $683.3K | n/a | 2020-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | 2025-12-31 | $8.62M | -0.9% |
| GRI Bio, Inc. (GRI) | 2025-12-31 | $8.67M | +51.0% |
| Palatin Technologies Inc (PTN) | 2026-06-30 | $8.52M | +160.9% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $8.75M | -11.7% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| Revium Rx. (RVRC) | 2025-12-31 | $8.30M | -59.1% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $8.97M | +26.9% |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $8.11M | n/a |
| ProMIS Neurosciences Inc. (PMN) | 2025-12-31 | $9.18M | -51.4% |
Compare CNSP, GRI, PTN, IGC side by side · Screen every company in Pharmaceutical Preparations ↗